Warning! GuruFocus detected
3 Severe warning signs
with RJH.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Rajthanee Hospital PCL
ISIN : TH7398010002
Description
Rajthanee Hospital PCL is operating in the healthcare sector. It is principally engaged in the provision of healthcare services. In hospital operations, it provides medical services such as cardiology center, emergency accident center, orthopedic center, hemodialysis center, pediatrics center, health screening center, dental center, and radiology center. Its customers include individuals, a group of policyholders of the insurance company, a group of contract parties' company, and a group of insured on social security.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.09 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.79 | |||||
| Debt-to-EBITDA | 2.31 | |||||
| Interest Coverage | 9.33 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.55 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -4.1 | |||||
| 3-Year EBITDA Growth Rate | -21.6 | |||||
| 3-Year EPS without NRI Growth Rate | -21.6 | |||||
| 3-Year Book Growth Rate | 2.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -7.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 2.95 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.67 | |||||
| 9-Day RSI | 23.06 | |||||
| 14-Day RSI | 26.97 | |||||
| 3-1 Month Momentum % | -27.57 | |||||
| 6-1 Month Momentum % | -34.04 | |||||
| 12-1 Month Momentum % | -37.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.71 | |||||
| Quick Ratio | 0.64 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 10.7 | |||||
| Days Sales Outstanding | 24.45 | |||||
| Days Payable | 56.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5 | |||||
| Dividend Payout Ratio | 0.46 | |||||
| 3-Year Dividend Growth Rate | -29.6 | |||||
| Forward Dividend Yield % | 5 | |||||
| 5-Year Yield-on-Cost % | 4.73 | |||||
| 3-Year Average Share Buyback Ratio | 0.7 | |||||
| Shareholder Yield % | 0.35 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.72 | |||||
| Operating Margin % | 17.95 | |||||
| Net Margin % | 18 | |||||
| FCF Margin % | -3.43 | |||||
| ROE % | 23.36 | |||||
| ROA % | 11.82 | |||||
| ROIC % | 12.73 | |||||
| 3-Year ROIIC % | -37.48 | |||||
| ROC (Joel Greenblatt) % | 19.51 | |||||
| ROCE % | 16.03 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.49 | |||||
| Forward PE Ratio | 9.62 | |||||
| PE Ratio without NRI | 8.65 | |||||
| Shiller PE Ratio | 8.79 | |||||
| Price-to-Owner-Earnings | 77.84 | |||||
| PEG Ratio | 1.97 | |||||
| PS Ratio | 1.54 | |||||
| PB Ratio | 2.02 | |||||
| Price-to-Tangible-Book | 2.13 | |||||
| Price-to-Operating-Cash-Flow | 7.05 | |||||
| EV-to-EBIT | 10.99 | |||||
| EV-to-Forward-EBIT | 19.28 | |||||
| EV-to-EBITDA | 8.46 | |||||
| EV-to-Forward-EBITDA | 15.41 | |||||
| EV-to-Revenue | 2.14 | |||||
| EV-to-Forward-Revenue | 4.47 | |||||
| EV-to-FCF | -65.76 | |||||
| Price-to-GF-Value | 0.51 | |||||
| Price-to-Projected-FCF | 0.95 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.21 | |||||
| Price-to-Graham-Number | 0.9 | |||||
| Earnings Yield (Greenblatt) % | 9.11 | |||||
| FCF Yield % | -2.29 | |||||
| Forward Rate of Return (Yacktman) % | 12.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rajthanee Hospital PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 2,738.579 | ||
| EPS (TTM) (฿) | 1.65 | ||
| Beta | 0.69 | ||
| 3-Year Sharpe Ratio | -1.58 | ||
| 3-Year Sortino Ratio | -1.54 | ||
| Volatility % | 19.79 | ||
| 14-Day RSI | 26.97 | ||
| 14-Day ATR (฿) | 0.534595 | ||
| 20-Day SMA (฿) | 15.235 | ||
| 12-1 Month Momentum % | -37.75 | ||
| 52-Week Range (฿) | 13.8 - 26.25 | ||
| Shares Outstanding (Mil) | 292.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rajthanee Hospital PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rajthanee Hospital PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rajthanee Hospital PCL Frequently Asked Questions
What is Rajthanee Hospital PCL(BKK:RJH)'s stock price today?
The current price of BKK:RJH is ฿14.00. The 52 week high of BKK:RJH is ฿26.25 and 52 week low is ฿13.80.
When is next earnings date of Rajthanee Hospital PCL(BKK:RJH)?
The next earnings date of Rajthanee Hospital PCL(BKK:RJH) is .
Does Rajthanee Hospital PCL(BKK:RJH) pay dividends? If so, how much?
The Dividend Yield %  of Rajthanee Hospital PCL(BKK:RJH) is 5% (As of Today), Highest Dividend Payout Ratio of Rajthanee Hospital PCL(BKK:RJH) was 1.07. The lowest was 0.32. And the median was 0.77. The  Forward Dividend Yield % of Rajthanee Hospital PCL(BKK:RJH) is 5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers